EPO Patents = 6

Forward Citations = 10

Loading Chart...

15 inventors (with patents filed for the assignee):

Jan Marie Cyriel Jozef Hoflack (4 out of 4 patents)

Petra Blom (3 out of 6 patents)

Jan Hoflack (3 out of 4 patents)

4. Petra Marcella Francoise Blom (3 out of 3 patents)

5. Caroline Robic (1 out of 6 patents)

6. Cyril Berthet (1 out of 1 patent)

7. Petra Marcella Françoise Blom (1 out of 1 patent)

8. Johnny Vercouillie (1 out of 1 patent)

9. Sarah Catoen (1 out of 1 patent)

10. Gilles Voit (1 out of 1 patent)

11. Jean-Bernard Deloye (1 out of 1 patent)

12. Pascal Benderitter (1 out of 1 patent)

13. Olivier Lavergne (1 out of 18 patents)

14. Sylvie Gomez (1 out of 1 patent)

15. Pascal Andre Rene Benderitter (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 10716869 - Radiolabeled macrocyclic EGFR inhibitor (2020-07-21),

2. 10676486 - Macrocyclic RIP2 kinase inhibitors (2020-06-09),

3. 10377772 - Macrocyclic LRRK2 kinase inhibitors (2019-08-13),

4. 9586975 - Macrocyclic salt-inducible kinase inhibitors (2017-03-07),

5. 9370519 - Macrocyclic FLT3 kinase inhibitors (2016-06-21),

6. 9096609 - Macrocyclic LRRK2 kinase inhibitors (2015-08-04),

7. 9090630 - Macrocyclic FLT3 kinase inhibitors (2015-07-28),

Oncodesign is a biotechnology company specializing in precision medicine and biomarker development. The company offers innovative solutions for personalized oncology treatment, drug discovery, and preclinical services. Oncodesign's expertise in molecular and cellular biology, pharmacology, and bioinformatics allows them to develop cutting-edge technologies and services for the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#5 in Dijon

#2,183 in France

Dijon, France

Oncodesign Sa